Objective
Interleukin-7 promotes survival and proliferation of lymphocytes both during thyrnic maturation and also in the case of mature peripheral cells. In HTV-infected individuals and in clinical settings, which result in T cell depletion an increase of serum, IL-7 concentration was found. Increased production of IL-7 in response to T cell loss is considered as a homeostatic response mechanism aiming at the restoration of peripheral T cell number. In our previous studies we found a decreased level of IL-7R in HIV-infected patients and the decrease of the receptor was correlated with the level of T cell depletion and also with the increase of serum IL-7 concentrations. These results suggest that low IL-7R expression of T cells may contribute to the loss of T lymphocytes in HIV-infected individuals and may also limit the positive effects of the high IL-7 concentration on T cells.
Our research objectives discussed in the proposal are the following:
1) Assay the hypothesis that low IL-7R expression of T lymphocytes in HIV positive subjects may result in survival disadvantage for peripheral T lymphocytes. Analyse if known apoptosis regulatory molecules are affected in 1L-7R negative T cells from HIV patients.
2) Analyse if dendritic cells (DC) can produce IL-7 and characterise those factors of DC maturation and activation, which regulate IL-7 expression. Test the hypothesis if DC can present IL-7 to T cells by binding the cytokine to the extracellular matrix with a similar mechanism described in the case of bone marrow stromal cells.
3) Analysis of the production and functon of the soluble IL-7Ra protein. We plan to screen which cells produce the soluble form of the IL-7R and analyse if the soluble receptor can interfere with the effects of IL-7.
4) Analyse if IL-7 plays a role in the regulation of HIV tropism.
Our research may open new lines of thinking in field of T cell homeostasis in HIV-infected individuals.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences biological sciences biochemistry biomolecules proteins
- medical and health sciences health sciences infectious diseases RNA viruses HIV
- medical and health sciences basic medicine physiology homeostasis
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP6-2002-MOBILITY-5
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
STOCKHOLM
Sweden
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.